Final results for the year ended 31 December 2025

AI SummaryClose X

Verici Dx plc reported final results for the year ended December 31, 2025, with total revenues of $3.7 million, comprising $2.9 million from Tutivia sales and $0.8 million from license income, compared to $3.3 million in the prior year. The company completed a $7.9 million net equity fundraise in July 2025 and ended the year with a $3.3 million cash balance, projecting a cash runway to the end of 2026. An adjusted EBITDA loss of $6.2 million was recorded, an increase from $5.4 million in 2024. Significant operational progress included securing Medicare coverage for Tutivia, leading to 1,173 test orders in FY25, a 250% increase from FY24. Post-period, a £2.6 million equity fundraise was completed in June 2026.

Disclaimer*

Companies

Verici DX (VRCI)
UK 100

Latest directors dealings